Jefferson University Hospitals

Physician Profile

Edith Mitchell, MD, FACP

Jefferson University Physician

Academic Title: Clinical Professor
Director, Center to Eliminate Cancer Disparities
Program Leader, Gastrointestinal Oncology

Specialties
Medical Oncology
Medical Oncology - Colorectal Cancer
Medical Oncology - Esophageal Cancer
Medical Oncology - Gastrointestinal (GI) Cancer
Medical Oncology - Liver Cancer
Medical Oncology - Pancreatic Cancer
Medical Oncology - Stomach Cancer

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
925 Chestnut Street
Suite 320A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 503-7697

Medical Services

Years in Practice

39

Board Certifications

  • Medical Oncology
  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Education

  • Medical College of Virginia, Medical School

Internship

  • Meharry Medical College

Residency

  • Meharry Medical College

Fellowship

  • Georgetown University Hospital, DC

Recent Publications

American Society of Clinical Oncology strategic plan for increasing racial and ethnic diversity in the oncology workforce

Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms

African American Patients’ Psychosocial Support Needs and Barriers to Treatment: Patient Needs Assessment

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

Moonshot Toward a Cure for Cancer

Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism

Positive association of fibroadenomatoid change with HER2-negative invasive breast cancer: A co-occurrence study

5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: A randomized Phase IIb study

Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer

Determinants of pain severity changes in ambulatory patients with cancer: An analysis from eastern cooperative oncology group trial E2Z02

Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA

Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

Targeted Therapy for Metastatic Colorectal Cancer: Role of Aflibercept